BMB Reports : eISSN 1976-670X

Cited by CrossRef (5)

  1. Janusz Matuszyk. MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy. Mol Med 2022;28
    https://doi.org/10.1186/s10020-022-00516-2
  2. Janina Werner, Patrick Bernhard, Miguel Cosenza-Contreras, Niko Pinter, Matthias Fahrner, Prama Pallavi, Johannes Eberhard, Peter Bronsert, Felix Rückert, Oliver Schilling. Targeted and explorative profiling of kallikrein proteases and global proteome biology of pancreatic ductal adenocarcinoma, chronic pancreatitis, and normal pancreas highlights disease-specific proteome remodelling. Neoplasia 2023;36:100871
    https://doi.org/10.1016/j.neo.2022.100871
  3. Marika Saar, Jana Jaal, Alvin Meltsov, Tõnis Laasfeld, Helen Lust, Sergo Kasvandik, Darja Lavogina. Exploring the Molecular Players behind the Potentiation of Chemotherapy Effects by Durvalumab in Lung Adenocarcinoma Cell Lines. Pharmaceutics 2023;15:1485
    https://doi.org/10.3390/pharmaceutics15051485
  4. Bruna O. de Almeida, Larissa C. de Almeida, Leticia V. Costa‐Lotufo, João A. Machado‐Neto. ANKHD1 contributes to the malignant phenotype of triple‐negative breast cancer cells. Cell Biology International 2022;46:1433
    https://doi.org/10.1002/cbin.11844
  5. Dianyun Ren, Yan Sun, Dan Li, Heshui Wu, Xin Jin. USP22‐mediated deubiquitination of PTEN inhibits pancreatic cancer progression by inducing p21 expression. Molecular Oncology 2022;16:1200
    https://doi.org/10.1002/1878-0261.13137